Onwards and Upwards6 Aug 2021 07:25
The syndicated posts here are starting to get annoying but its how it is i guess.
Businesses are being acquired at significant multiples of Novacyt's current market cap. As at today it sits at a mcap of £216m yet cash at bank by the end of this year will be in the region of £150m on its own.
So a baseless deramp predicting doom and gloom and how the SP will be £ 2 , in other words less than its cash at bank balance and that's before we consider its world class bioinformatics business, all of it's IP and goodwill, its R&D division, the four trading businesses Lab 21, Primer Design, Microgen, the manufacturing business IT-IS and also the new stateside division Novacyt nc is simply ridiculous.
Anyhow, onwards and upwards from here, we have seen it all before. I'm still buying into it, ultimately the fundamentals will out and the share price catch up with them
GLA